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This past year we have made substantial progress in modeling the contribution of 
homeostatic regulation to low-dose radiation effects and carcinogenesis.  We have 
worked to refine and apply our multistage carcinogenesis models to explicitly incorporate 
cell cycle states, simple and complex damage, checkpoint delay, slow and fast repair, 
differentiation, and apoptosis to study the effects of low-dose ionizing radiation in mouse 
intestinal crypts, as well as in other tissues.  We have one paper accepted for publication 
in ‘Advances in Space Research’, and another manuscript in preparation describing this 
work.  I also wrote a chapter describing our combined cell-cycle and multistage 
carcinogenesis model that will be published in a book on stochastic carcinogenesis 
models edited by Wei-Yuan Tan.  In addition, we organized and held a workshop on 
‘Biologically Based Modeling of Human Health Effects of Low dose Ionizing Radiation’, 
July 28-29, 2005 at Fred Hutchinson Cancer Research Center in Seattle, Washington.  
We had over 20 participants, including Mary Helen Barcellos-Hoff as keynote speaker, 
talks by most of the low-dose modelers in the DOE low-dose program, experimentalists 
including Les Redpath (and Mary Helen), Noelle Metting from DOE, and Tony Brooks.  
 
It appears that homeostatic regulation may be central to understanding low-dose radiation 
phenomena.  The primary effects of ionizing radiation (IR) are cell killing, delayed cell 
cycling, and induction of mutations.  However, homeostatic regulation causes cells that 
are killed or damaged by IR to eventually be replaced.  Cells with an initiating mutation 
may have a replacement advantage, leading to clonal expansion of these initiated cells.  
Thus we have focused particularly on modeling effects that disturb homeostatic 
regulation as early steps in the carcinogenic process.   
 
There are two primary considerations that support our focus on homeostatic regulation.  
First, a number of epidemiologic studies using multistage carcinogenesis models that 
incorporate the ‘initiation, promotion, and malignant conversion’ paradigm of 
carcinogenesis are indicating that promotion of initiated cells is the most important 
cellular mechanism driving the shape of the age specific hazard for many types of cancer.  
Second, we have realized that many of the genes that are modified in early stages of the 
carcinogenic process contribute to one or more of four general cellular pathways that 
confer a promotional advantage to cells when these pathways are disrupted.   
 
Four general cellular pathways that can increase the promotional advantage of cells are:    
1.)  Cell signaling pathways that cause diminished homeostatic control, including 
Wnt/APC/beta-catanin, TGF-beta, BMP, Notch, Par  that lead to cancers such as colo-
rectal, liver, breast, and other epithelial cancers;   
2.)  Sensing, repair of DNA damage pathways that cause continued cycling, and genetic 
instability, including  Rad9/Rad1/Hus2, ATM, DNA-PK, ATR, BRCA1, Rad 51, Rad52 
that lead to cancers such as colon, breast, gastric, and thyroid.  
3.)  Checkpoint control pathways with disruption causing reduced repair, faster cycling, 
instability, involving P21, P53, BRCA1, Rb/p16INK4a, Chk1, Chk2, ATM/ATR that 
lead to cancers such as non-small cell lung cancer, melanoma, ovarian, and prostate. 
4.)  Apoptosis pathways with reduced apoptosis causing a promotional advantage and 
more surviving mutations, involving Bcl-2, P53, PI3K/AKT/Survivin, and Ki67, as seen 
in leukemias, astrocytic, small cell lung, breast, and gastric cancers.   
 
Disruption of any of these four general pathways can be modeled within the framework 
of our combined cell cycle and multistage carcinogenesis model.   
 
We have initially applied the model to study mouse intestinal crypts because of their 
sensitive radiation response, and because of the ability to knockout specific genes 
regulating apoptosis, checkpoint control, and other cell cycle regulatory features.   
 
In modeling the mouse intestinal crypts, we incorporate homeostatic regulation at the 
individual crypt level to maintain a target of approximately 16 stem cells per crypt.  As 
this target number is approached, the model causes the rate of progression out of the G1 
cell cycle state to diminish.  Thus cells in G1 stage become blocked, effectively going 
into G0 state.  The model incorporates differentiation out of G1 based on a circadian 
rhythm, with homeostatic regulation then leading to division of a few stem cells.  The 
dividing cells are much more susceptible to radiation.  Thus the model predicts a few (3-
4) highly sensitive stem cells that apoptosis with low-dose IR, with the remaining stem 
cells in G0 highly resistant to radiation.   These model results are in general agreement 
with experimental data. 
  
 If future funding becomes available, we plan to collaborate with Chris Kemp here at 
FHCRC, who is an expert in these mouse systems.  In anticipation of this, we have 
worked with Chris on a preliminary analysis looking at changes in mitotic index as a 
function of IR dose for p27 +/+, +/-, and -/- mice to study the effects of disregulation of 
the G2/M checkpoint.  The early results appear promising, but we need extended funding 
to pursue our preliminary findings. 
 
 
 
 
 
   
 
 
